Development and validation of an instrument to assess treatment adherence for each individual drug taken by a patient

Abstract

Objective: To develop and validate an instrument to assess adherence to each individual drug taken by patients undergoing long-term treatment. Design: Multicentre prospective observational validation study. Setting: Six general practitioners' clinics and 6 university hospitals in Paris, France. Participants: Patients 18 years and older receiving at least one long-term treatment. Methods: The instrument was developed from a literature search and interviews with experts. Clarity and wording were assessed during pilot testing with 1 patients. The tool was validated in a sample of consecutive patients. We assessed agreement between adherence measured with our tool and drug diaries and compared measurements from our instrument with (1) the Lu instrument; (2) the Adherence Estimator (AE); (3) patient's adherence assessed by physicians; (4) the Morisky Medication Adherence Scale-4 items (MMAS-4); and (5) the Treatment Burden Questionnaire (TBQ). Reliability was assessed by a test-retest method. Results: A total of 243 patients taking 961 drugs were recruited in 2014. We found good agreement between adherence measured by our tool and drug diaries (intraclass correlation coefficient (ICC) 0.69, 95% CI 0.34 to 0.91) and a linear relationship between measurement with our tool and (1) the Lu instrument (p<0.01); (2) 2 items of the AE (perceived need for medication ( p<0.01) and concerns about medication (p<0.01)); (3) patients' adherence assessed by their physicians (p<0.01); (4) the MMAS-4 (p<0.01) and (5) the TBQ (p<0.01). Reliability of the retest was good (ICC 0.67, 95% CI 0.42 to 0.85). onclusions: We developed an instrument with acceptable validity and reliability to assess adherence for each drug taken by patients, usable in hospital and primary care settings.